Abstract
Background: Cooking and heating in households contribute importantly to air pollution exposure worldwide. However, there is insufficient investigation of measured fine particulate matter (PM2.5) exposure levels, variability, seasonality, and inter-spatial dynamics associated with these behaviours.
Methods: We undertook parallel measurements of personal, household (kitchen and living room), and community PM2.5 in summer (May-September 2017) and winter (November 2017-Janauary 2018) in ∼480 participants from one urban and two rural communities in China. These recorded ∼61,000-81,000 person-hours of processed data per microenvironment. Age- and sex-adjusted geometric means of PM2.5 were calculated by key participant characteristics, overall and by season. Spearman correlation coefficients between PM2.5 levels across different microenvironments were computed.
Findings: Overall, 25.1% reported use of solid fuel for both cooking and heating. Solid fuel users had ∼90% higher personal and kitchen 24-hour average PM2.5 exposure than clean fuel users. Similarly, they also had a greater increase (∼75% vs ∼20%) in personal and household PM2.5 from summer to winter, whereas community levels of PM2.5 were 2-3 times higher in winter regardless of fuel use. Compared with clean fuel users, solid fuel users had markedly higher weighted annual average PM2.5 exposure at personal (77.8 [95% CI 71.1-85.2] vs ∼40 µg/m3), kitchen (103.7 [91.5-117.6] vs ∼50 µg/m3) and living room (62.0 [57.1-67.4] vs ∼40 µg/m3) microenvironments. There was a remarkable diurnal variability in PM2.5 exposure among the participants, with 5-minute moving average 700-1,200µg/m3 in typical meal times. Personal PM2.5 was moderately correlated with living room (Spearman r: 0.64-0.66) and kitchen (0.52-0.59) levels, but only weakly correlated with community levels, especially in summer (0.15-0.34) and among solid fuel users (0.11-0.31).
Conclusion: Solid fuel use for cooking and heating was associated with substantially higher personal and household PM2.5 exposure than clean fuel users. Household PM2.5 appeared a better proxy of personal exposure than community PM2.5 in this setting.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The CKB baseline survey and the first re-survey were supported by the Kadoorie Charitable Foundation in Hong Kong. The long–term follow-up has been supported by Wellcome grants to Oxford University (212946/Z/18/Z, 202922/Z/16/Z, 104085/Z/14/Z, 088158/Z/09/Z) and grants from the National Natural Science Foundation of China (82192900, 82192901, 82192904) and from the National Key Research and Development Program of China (2016YFC0900500).The UK Medical Research Council (MC–UU–00017/1,MC–UU–12026/2, MC–U137686851), Cancer Research UK (C16077/A29186; C500/A16896) and the British Heart Foundation (CH/1996001/9454), provide core funding to the Clinical Trial Service Unit and Epidemiological Studies Unit at Oxford University for the project. KHC acknowledges support from the BHF Centre of Research Excellence, University of Oxford (RE/18/3/34214). AD is supported by the Wellcome Trust (223100/Z21/Z). The CKB-Air study was supported by a UK Medical Research Council: Global Challenges Research Fund – Foundation Award (Ref MR/P025080/1) and a Nuffield Department of Population Health Pump-priming Award.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Oxford University Tropical Research Ethics Committee, Oxford, UK (Ref: 5109-17) and the institutional review board of Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, China (Ref: 2018-1038). All participants provided written informed consent upon recruitment.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The China Kadoorie Biobank (CKB) is a global resource for the investigation of lifestyle, environmental, blood biochemical and genetic factors as determinants of common diseases. The CKB study group is committed to making the cohort data available to the scientific community in China, the UK and worldwide to advance knowledge about the causes, prevention and treatment of disease. For detailed information on what data is currently available to open access users and how to apply for it, visit: http://www.ckbiobank.org/site/Data+Access. Researchers who are interested in obtaining the raw data from the China Kadoorie Biobank study that underlines this paper should contact ckbaccess{at}ndph.ox.ac.uk. A research proposal will be requested to ensure that any analysis is performed by bona fide researchers.
